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Improved 11α-hydroxycanrenone production by modification of 
cytochrome P450 monooxygenase gene in Aspergillus ochraceus
Eplerenone is a drug that protects the cardiovascular system. 
11α-Hydroxycanrenone is a key intermediate in eplerenone 
synthesis. We found that although the cytochrome P450 
(CYP) enzyme system in Aspergillus ochraceus strain MF018 
could catalyse the conversion of canrenone to 11α-hydroxy-
canrenone, its biocatalytic efficiency is low. To improve the 
efficiency of 11α-hydroxycanrenone production, the CYP 
monooxygenase-coding gene of MF018 was predicted and 
cloned based on whole-genome sequencing results. A recom-
binant A. ochraceus strain MF010 with the high expression of 
CYP monooxygenase was then obtained through homolo-
gous recombination. The biocatalytic rate of this recombinant 
strain reached 93 % at 60 h without the addition of organic 
solvents or surfactants and was 17–18 % higher than that of 
the MF018 strain. Moreover, the biocatalytic time of the 
MF010 strain was reduced by more than 30 h compared 
with that of the MF018 strain. These results show that the 
recombinant A. ochraceus strain MF010 can overcome the 
limitation of substrate biocatalytic efficiency and thus holds 
a high poten tial for application in the industrial production 
of eplerenone.
Keywords: Aspergillus ochraceus, P450 monooxygenase, homo-
logous recombination, canrenone, 11α-hydroxycanrenone
Steroids are a group of compounds that contain a four-ring structure, termed as the 
cyclopentanoperhydrophenanthrene nucleus, and possess a wide range of pharmacolo-
gical activities (1–3). Although natural steroids tend to have low pharmacological activity, 
their pharmacological and biological activities can be drastically enhanced by introducing 
specific chemical groups at specific sites (1, 4, 5). These sites, such as C11α, C11β, C9α and 
C16α, are important hydroxylation sites. C11α-hydroxylation is one of the most important 
reactions (2, 6) because the modification of C11α, a physiologically active group, can greatly 
increase therapeutic effects, reduce side effects and change the specificity of steroids (7).
Canrenone, a cardiovascular drug, is a steroid hormone that is used primarily as a 
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diseases by blocking the renin-angiotensin-aldosterone system (8, 9). However, canrenone 
has a negative interference effect on the cardiotonic compound digoxin; thus, the use of 
canrenone in heart disease treatment may cause dangerous side effects or death (8, 10). The 
derivatives of canrenone are developed via nitration, hydroxylation and other modifica-
tions to enhance its efficacy and reduce side effects (11). Amongst these methods, the 
11α-hydroxylation of canrenone by microorganisms to produce 11α-hydroxycanrenone is 
a promising strategy for producing modified canrenone derivatives.
Eplerenone is a new selective steroidal aldosterone receptor antagonist. Clinical studies 
have demonstrated that in cardiovascular diseases, such as hypertension, the side effects 
and mortality associated with heart failure disorders are significantly reduced by eplerenone 
treatment compared with those by canrenone treatment (12–14). The chemical synthesis of 
eplerenone is a six-step process with 11α-hydroxycanrenone as an intermediate (15). Micro-
bial catalytic conversion from canrenone to 11α-hydroxycanrenone is the first and the most 
critical step during eplerenone synthesis (16, 17).
The 11α-hydroxylation of steroids in microorganisms is associated with the intra-
cellular enzyme 11α-hydroxylase, which belongs to the cytochrome P450 (CYP)-dependent 
monooxygenase family (18, 19). This enzyme introduces oxygen atoms at specific sites in 
the steroid backbone to convert lipophilic steroidal compounds into relatively hydrophilic 
derivatives (18). Cytochrome C reductase (CPR) and hexane oxidase are mediated by CYP 
in Aspergillus ochraceus, and these CYP-linked monooxygenases can be used to catalyse the 
conversion of cycloxanthone into 11α-hydroxyxanthone (19, 20). However, the biocatalytic 
specificities of A. ochraceus vary for different steroid substrates, and its catalytic efficiency 
is low. Increasing the catalytic efficiency of A. ochraceus for steroids involves two aspects: 
the optimisation of fermentation conditions and the genetic modification of strains. To 
date, many studies have focused on the optimisation of the fermentation conditions of 
steroids produced by A. ochraceus, but few have focused on the genetic modification of A. 
ochraceus. The genetic modification approach can help resolve key technical difficulties and 
improve the efficiency of steroid catalysis.
An A. ochraceus strain MF018 with the ability to 11α-hydroxylate steroids was isolated 
in our laboratory, but its biocatalytic efficiency was found to be low. To improve the effi-
ciency, a recombinant A. ochraceus strain with high expression of the CYP monooxygenase 
gene under the control of the Tr promoter was constructed via homologous recombination. 
This strain could improve the biocatalytic efficiency of the 11α-hydroxylation of steroids 
and exhibits potential industrial applications.
EXPERIMENTAL
Strain and culture conditions
Escherichia coli DH5α and A. ochraceus MF018 strains were preserved in the laboratory. A 
single colony of E. coli DH5α was inoculated in Luria-Bertani medium (21) with 100 μg mL–1 
ampicillin and cultured at 37 °C and 200 rpm overnight.
The spores of A. ochraceus were collected on potato dextrose agar (PDA) medium (22, 
23) and cultured in seed medium (6 g L–1 glucose, 4 g L–1 soluble starch, 20 g L–1 corn syrup, 
10 g L–1 peptone, 1 g L–1 NH4H2PO4, 2 g L–1 MgCl2, pH 6.4) at 28 °C and 180 rpm for 18 h. 
101
Q. Li et al.: Improved 11α-hydroxycanrenone production by modification of cytochrome P450 monooxygenase gene in Aspergillus 
ochraceus, Acta Pharm. 71 (2021) 99–114.
 
The culture was transferred to fermentation medium (25 g L–1 glucose, 10 g L–1 soluble 
starch, 20 g L–1 corn syrup, 10 g L–1 peptone, 1 g L–1 NH4H2PO4, 2 g L–1 MgCl2, natural pH) 
with an inoculum size of 75 mg mycelium dry weight per litre and was cultured at 28 °C 
and 200 rpm.
Whole-genome sequencing of A. ochraceus and prediction of the CYP  
monooxygenase gene
The genomic DNA of A. ochraceus MF018 was extracted using an OMEGA-DNA 
 extraction kit and sent to Suzhou GENEWIZ for whole-genome sequencing. The genomic 
sequence of A. ochraceus MF018 was determined using PacBio sequel systems powered by 
single-molecule real-time (SMRT) sequencing technology. The genome was assembled 
using Falcon. The assembly results were corrected by using the calibration software Quiver 
(version 1.1.0). For gene prediction, the start sites and coding regions were effectively  predicted 
using the software Augustus (version 3.3). Noncoding RNAs were obtained through sequence 
alignment with the Rfam database (version 12.0). Target sequences were searched using 
blast-2.2.30+111 following the CYP monooxygenase gene (GenBank No. ABH71415.1).
Antibiotic resistance screening of A. ochraceus MF018
The spores of A. ochraceus MF018 were collected from PDA medium and resuspended 
in sterile 0.9 % NaCl solution at a concentration of 107–108 mL–1. Next, 100 μL of spore sus-
pension was applied to PDA medium containing hygromycin B or bleomycin (Blm) at final 
concentrations of 50, 75, 100, 125, 150 and 200 μg mL–1 for each antibiotic. Cells were cul-
tured at 28 °C for 4–6 days. The experiments were repeated three times.
Gene cloning and construction of the recombinant plasmid
The characteristics of primers and plasmids used in this study are shown in Tables I 
and II, respectively. The strategy for fusion gene construction is shown in Fig. 1a. 
The polymerase chain reaction (PCR) primer pairs (Table I) were designed based on 
the predicted CYP monooxygenase gene (cypm). The PCR amplification parameters were 1 
cycle of denaturation (95 °C for 5 min), 30 cycles of extension (95 °C for 45 s, 53 °C for 30 s 
and 72 °C for 1 min 35 s) and 1 cycle of annealing (72 °C for 10 min). The cypm gene was 
cloned using the genomic DNA of A. ochraceus MF018 as a template. The cloned gene was 
inserted into the vector pMD-18T (Table II) to construct the plasmid pMD18-Cyp.
The upstream homologous arm sequence of cypm (Up) was amplified through PCR 
using F-Up/R-Up as the primer pair and A. ochraceus MF018 genomic DNA as the template. 
Then, the plasmid pMD18-Up was constructed. Similarly, the downstream homologous 
arm sequence of cypm (Down) was amplified by applying the same PCR protocol using 
primer pair F-Down/R-Down and A. ochraceus MF018 genomic DNA as a template. Then, 
the plasmid pMD18-Down was constructed. The promoter sequence (Tr) was amplified by 
using F-Tr/R-Tr as the primer pair and pSilent as the template to construct the plasmid 
pMD18-Tr. The hygromycin resistance gene (hyg) was amplified using F-Tr/R-Hyg as the 
primer pair and the plasmid pAg1-H3 as the template to construct the plasmid pMD18-
Hyg.
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Fusion PCR was performed to ligate the Up, Tr, cypm, hyg and Down fragments to-
gether (Fig. 1a). The constructed complete fusion fragment (UTPHD) was inserted into the 
plasmid pB-Hygro to construct the recombinant plasmid. The method is described in de-
tail below:
First step: The upstream homologous arm fusion fragment (U-L1R) was amplified us-
ing the primer pair F-Up/R-link1 and pMD18-Up as the template. The promoter fusion 
fragment (T-L1F) was amplified using the primer pair F-link1/R-Tr and pMD18-Tr as the 
Table I. Primer sequences for construction of recombinant strains and description







F-Down ACTCTAACTGCCGATGGAG Downstream homology 
arm sequence of cypmR-Down ATGCCCTTCTTCACTGGGCTTCT
F-Up GGTGATACAATGATTCGGAGA Upstream homology 
arm sequence of cypmR-Up GATAATGAGCTGTCAGCTTGTGG

















F-Screen  CCAGTCAACCTTCTCGGTCG Verification of the 
recombinant strainR-Screen GCTGGCAGAGTGCACTTCG
a Cytochrome P450 monooxygenase gene.
b The fusion fragment of upstream homologous arm sequence of cypm and Tr.
c The fusion fragment of the UT and cypm.
d The fusion fragment of hygromycin resistance gene and downstream homologous arm sequence of cypm.
e The complete fusion gene fragment of the UTP and HD.
103
Q. Li et al.: Improved 11α-hydroxycanrenone production by modification of cytochrome P450 monooxygenase gene in Aspergillus 
ochraceus, Acta Pharm. 71 (2021) 99–114.
 
template. The PCR products were detected through gel electrophoresis, and the target 
bands were purified by gel recovery (SanPrep Column DNA Gel Extraction Kit).
Second step: The PCR amplification was performed using 0.5 μL of TaKaRa LA Taq (5 
U μL–1), 2.5 μL of 10× LA Taq Buffer II (Mg2+ Plus), 4 μL of dNTP Mixture (2.5 mM each), 1 
μL of template U-L1R (< 1 μg), 1 μL of template T-L1F (< 1 μg) and 16 μL of H2O. Primers 
F-Up and R-Tr were added after 10 cycles of amplification in accordance to the procedure 
described above, and amplification was performed for 20 cycles. The upstream homolo-
gous arm of cypm and the promoter sequence fusion fragment (UT) were purified, and the 
recombinant plasmid pMD18-UT was constructed.
Third step: The plasmids pMD18-UT and pMD18-Cyp were used as templates to am-
plify the fusion fragment (UTP) with the upstream homologous arm of cypm, the pro-
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moter sequence and cypm using the same strategy as that described in the second step. The 
primer pairs F-Up/R-link2, F-link2/R-Cyp and F-Up/R-Cyp were used with both templates.
Fourth step: The plasmids pMD18-Hyg and pMD18-Down were used as templates to 
amplify the fusion fragment (HD) with the hyg gene and the downstream homologous arm 
of cypm using the same strategy as that described in the second step. The primer pairs F-
Tr/R-link3, F-link3/R-Down and F-Tr/R-Down were used.
Fifth step: The plasmids pMD18-UTP and pMD18-HD were used as templates to am-
plify the UTPHD with fusion fragments UTP and HD using the same strategy as that de-
scribed in the second step. The primer pairs F-Up/R-link4, F-link4/R-Down and F-Su/R-Ad 
were used.
The plasmid pMD18-UTPHD was digested with the restriction enzymes Aap I and Spe 
I. The fusion gene fragment UTPHD was then purified and inserted into the pB-hygro 
plasmid digested with the same restriction enzymes, and the recombinant plasmid desig-
Table II. Plasmids and the description
Plasmids Description Source
pMD18-T Ampicillin resistance gene (Ampr) Takara Co. Ltd.
pB-Hygro E. coli/A. ochraceus shuttle vector, chlorampheni-col resistance gene Fenghui Bio Co. Ltd.
pSilent-Dual For amplification of Tr promoter sequence, Ampr Fenghui Bio Co. Ltd.
pAgI-H3 For amplification of hygromycin resistance gene, kanamycin resistance gene Miao Ling Plasmid Co. Ltd.
pMD18-Cyp Containing the cypma, Ampr This research
pMD18-Tr Containing Tr promoter sequence, Ampr This research
pMD18-Up Containing upstream homologous arm sequence of cypm, Ampr This research
pMD18-Down Containing downstream homologous arm sequence of cypm, Ampr This research
pMD18-Hyg Containing hygromycin resistance gene, Ampr This research
pMD18-UT Containing the fusion fragment UTb, Ampr This research
pMD18-UTP Containing the fusion fragment UTPc, Ampr This research
pMD18-HD Containing the fusion fragment HDd, Ampr This research
pMD18-UTPHD Containing the complete fusion fragment UTPHDe, Ampr This research
pB-UTPHD Recombinant plasmid, hyg This research
a Cytochrome P450 monooxygenase gene.
b The fusion fragment of upstream homologous arm sequence of cypm and Tr.
c The fusion fragment of the UT and cypm.
d The fusion fragment of hygromycin resistance gene and downstream homologous arm sequence of cypm.
e The complete fusion gene fragment of the UTP and HD.
105
Q. Li et al.: Improved 11α-hydroxycanrenone production by modification of cytochrome P450 monooxygenase gene in Aspergillus 
ochraceus, Acta Pharm. 71 (2021) 99–114.
 
nated pB-UTPHD was constructed (Fig. 1b). The plasmid pB-UTPHD was then trans-
formed into E. coli DH5α competent cells (24) and screened for chloramphenicol resistance 
(20 μg mL–1). Positive transformants were verified through PCR using the primer pairs F-
Down/R-Ad, F-Tr/R-Hyg, F-Cyp/R-Cyp and F-Su/R-Tr. Then, the recombinant plasmid pB-
UTPHD was sequenced to confirm the absence of any mutation generated by PCR.
Preparation of A. ochraceus protoplasts and transformation
The protoplasts of A. ochraceus MF018 were prepared, and the plasmid pB-UTPHD 
was transformed as described by Weyda et al. (25, 26). The protoplasts were cultured for 
6–8 h in RM medium (1 g L–1 casein amino acid, 1 g L–1 yeast extract, 274 g L–1 sucrose). The 
cells were applied to the PDA medium containing 125 μg mL–1 hygromycin B and cultured 
at 28 °C for 5–6 days. Positive transformants were propagated for 6–7 generations to assess 
their stability before being verified by PCR amplification using the primers F-Screen and 
R-Screen (Table I). A. ochraceus MF018 was used as the negative control.
Growth curve determination
The constructed A. ochraceus MF010 was cultured as described above. A total of 50 mL 
of culture was taken at 5-h intervals and filtered. The mycelia were then dried to a constant 
weight. A. ochraceus MF018 was used as negative control.
Determination of conversion products by HPLC-MS
A. ochraceus MF010 was cultured as described above. Canrenone was added after 18 h 
of culture at a final concentration of 20 g L–1. After 24 h of incubation at 28 °C and 200 rpm, 
the sample was extracted with 2 volumes of ethyl acetate. The supernatant was then di-
luted 50 times with methanol and analysed by HPLC-MS. The chromatographic conditions 
applied: a mobile phase methanol/water (8:2, V/V), the injection volume 10 μL, the flow rate 
of 0.8 mL min–1. Mass spectrometry analysis was performed as described by Huang et al. 
(17, 27).
Determination of canrenone and 11α-hydroxycanrenone by HPLC
A. ochraceus MF010 was cultured as described above. The concentration of canrenone 
substrate was determined at every 12-h interval. The canrenone conversion rate was cal-
culated using Equation 1:








where X and Y are 11α-hydroxycanrenone (g L–1) and canrenone (g L–1), respectively. A. 
ochraceus MF018 was used as negative control.
Data analysis
Statistical analysis was performed using OriginPro 2016. All quantitative data are 
expressed as the mean ± standard deviation for each condition.
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RESULTS AND DISCUSSION
Annotation of the A. ochraceus genome and prediction of the cypm
The genomic sequence of the A. ochraceus strain MF018 was determined by using 
PacBio’s SMRT sequencing technology with a highly accurate sequencing of over 99.999 % 
(QV50) independent of the GC and AT content of DNA sequences. The draft genome of A. 
ochraceus MF018 consisted of 164 sequence contigs with a total length of 3,709,426 bp and 
an N50 value of 1,732,139 bp. The average contig length was 226,184.52 bp, and the G+C 
content was 48.74 %. The numbers of predicted protein-coding genes and ncRNAs were 
10,535 and 1235, respectively. The average protein-coding gene density was 1 gene per 
1638.09 bp. The protein-coding sequences occupied 46.5 % of the sequenced portion of the 
A. ochraceus MF018 genome. Genomic information has been published in GenBank (Gen-
Bank No. VBTP00000000).
The cypm gene, which has a total length of 1834 bp, was retrieved from the sequencing 
assembly result of A. ochraceus MF018 using the software blast-2.2.30+111. Its similarity 
with the previously reported CYP monooxygenase gene (GenBank: ABH71415.1) was 99 % 
(28). Sequence alignment revealed that the cypm gene of A. ochraceus MF018 contained four 
introns with a coding sequence length of 1542 bp.
Antibiotic resistance gene selection
The antibiotic resistance gene hyg was selected as a screening marker for the recom-
binant strain. The antibiotic resistance of the unmodified A. ochraceus strain MF018 was 
determined first. The number of A. ochraceus MF018 colony-forming units was 0 when the 
hygromycin B concentration exceeded 100 μg mL–1 and the concentration of Blm reached 
125 μg mL–1. The growth inhibition of A. ochraceus MF018 by hygromycin B was higher 
than that by Blm at the same concentration. Hygromycin B was used at a final concentra-
tion of 125 μg mL–1 to reduce the impact of false-positive strains during the construction 
of the recombinant strain.
Construction of the recombinant plasmid pB-UTPHD
An 1834-bp sequence of the cypm gene was obtained using the genomic DNA of A. 
ochraceus MF018 as a template (Fig. 2a). The sequences of Up, Down, Tr and hyg were 1011, 
610, 359 and 1908 bp, respectively. Using these DNA fragments, the sequences of the fusion 
gene fragments UT, UTP and HD were 1370, 3204 and 2518 bp, respectively. The sequence 
of the fusion fragment UTPHD was 5722 bp. The profile of the recombinant plasmid pB-
UTPHD and the PCR results are shown in Fig. 1b and Fig. 2b, respectively. The sequencing 
results were consistent with the predictions, and the successful construction of the recom-
binant plasmid pB-UTPHD was confirmed.
Construction of recombinant A. ochraceus MF010
The recombinant plasmid pB-UTPHD was transferred into the A. ochraceus MF018 
recipient strain as described by Yang and Weyda et al. (25, 26). To confirm the double 
 crossover at the cypm position in the chromosome of A. ochraceus MF018, a 6016-bp gene 
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 fragment (designated as Sc-UTPHD) was amplified through PCR by using the primer pair 
F-Screen/R-Screen (Fig. 2c). Additionally, a 3750-bp gene fragment (designated as Sc-upd) 
was amplified from A. ochraceus MF018 as the negative control by using the same primers 
(Fig. 2c). In summary, A. ochraceus MF010 with the desired cypm mutation was constructed 
through homologous recombination by double crossover.
Growth curve of A. ochraceus MF010
The growth curve of A. ochraceus MF010 strain was determined to determine the influ-
ence of homologous recombination with the modified cypm on the growth of this strain. 
A. ochraceus MF018 was used as the control. The growth retardation period, logarithmic 
growth phase, stationary growth period and decline period were 0–8, 8–31, 31–50 and 50 
h, respectively. The growth curve of A. ochraceus MF010 was almost the same as that of A. 
ochraceus MF018. A. ochraceus MF010 showed good growth conditions, strong cell viability 
and normal basal metabolism.
Biocatalytic conversion of canrenone to 11α-hydroxycanrenone by A. ochraceus MF010
After culturing, the product of A. ochraceus MF010 was analysed through HPLC-MS. 
The molecular weight of the canrenone substrate was 341.29 after adding a hydrogen atom 
and 363.26 after adding a sodium atom (Fig. 3a). Therefore, the molecular weight of the 
canrenone substrate was approximately 340.27. The molecular weight of the biocatalytic 
product was 357.27 after adding a hydrogen atom and 379.25 after adding a sodium atom 
(Fig. 3b). Thus, the molecular weight of the product was approximately 356.26, i.e. 
Fig. 2. Agarose gel electrophoresis analysis of PCR products of: a) the cypm and b) the recombinant 
plasmid pB-UTPHD; c) the fragments amplified from the genomic DNA of A. ochraceus MF018 and 
MF010. cypm, cytochrome P450 monooxygenase gene; Down, Downstream homology arm sequence 
of cypm; hyg, hygromycin resistance gene; UT, the fusion fragment of upstream homologous arm 
 sequence of cypm and Tr promoter sequence; Sc-upd, PCR products amplified from the MF018 
 genomic DNA template; Sc-UTPHD, PCR products amplified from the MF010 genomic DNA template.
a)                                                        b)                                                  c)
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 approximately 16 more than that of the canrenone substrate. The data were consistent with 
those reported previously (17, 27, 29) and the standards (Fig. 3c and 3d). These data demon-
strated that A. ochraceus strain MF010 catalyses canrenone to 11α-hydroxycanrenone. 
Fig. 3. HPLC-MS spectra of: a) canrenone in culture after biocatalysis, b) 11α-hydroxycanrenone in culture 
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 Additionally, the HPLC results showed that the retention times of the product and substrate 
were 5.023 and 6.673 min, respectively (Fig. 4a). The results were consistent with the standards 
of 11α-hydroxycanrenone and canrenone (Fig. 4b).
Further, the substrate conversion rate was calculated on the basis of the peak area. 
When canrenone was added at a final concentration of 20 g L–1, the substrate biocatalytic 
conversion rate of A. ochraceus MF010 exceeded that of A. ochraceus MF018 (Fig. 5). Without 
the addition of any organic solvent or surfactant, the substrate conversion rate of A. ochraceus 
MF010 reached 93 % at 60 h, whereas that of A. ochraceus MF018 reached 75 % at 96 h. The 
highest conversion rate of A. ochraceus MF010 was 17–18 % higher than that of A. ochraceus 
MF018. The biocatalytic time of A. ochraceus MF010 was also reduced by more than 30 h 
compared with that of A. ochraceus MF018. These results indicated that the conversion rate 
of A. ochraceus MF010 was superior to that of A. ochraceus MF018 with a significantly shorter 
biocatalytic time.
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Many recent studies have focused on improving the biocatalytic efficiency in terms of 
cell immobilisation or selection and the optimisation of fermentation conditions. Houng 
et al. (30) reported a novel cell immobilisation technique that was developed for increasing 
substrate partitioning to the gel matrix by coating a thin polyurea layer on the surfaces of 
calcium alginate beads. This method improved the efficiency of the conversion of proge-
sterone to 11α-hydroxyprogesterone by A. ochraceus. Rong et al. (31) reported a new method 
for the biocatalytic conversion of β-sitosterol to 11α-hydroxyandrosta-1,4-diene-3,17-dione 
(11α-OH-ADD) through the cultivation of a Mycobacterium MF006 and A. ochraceus MF007 
mixture with hollow organic silica spheres. This method improved the dispersibility of the 
substrate based on its excellent adsorption properties, thereby improving the conversion 
efficiency of β-sitosterol to 11α-OH-ADD. These studies focused on improving the effi-
ciency of the catalytic process of A. ochraceus but did not change the genetic characteristics 
of the strain. Wang et al. (32) identified a novel 11α-hydroxylase gene CYP5311B1 from 
Absidia coerulea AS3.65 through heterologous expression in Pichia pastoris. Its expression at 
the transcriptional level could be highly induced by steroid substrates. Another 
11α-hydroxylase gene called CYP509C12 from Rhizopus oryzae was cloned and identified, 
and its heterologous expression and functional identification were performed in fission 
yeast (33). Hull et al. (34) reported that the genes encoding 11α-steroid hydroxylase  enzymes 
from A. ochraceus and R. oryzae could be transformed into Saccharomyces cerevisiae for 
 heterologous constitutive expression and that both recombinant yeasts exhibited the 
 efficient bioconversion of progesterone.
The electrons required for the catalytic activity of the fungal steroid hydroxylase are 
provided by NAD(P)H-CYP reductase. Electron transfer to CYP can be a rate-limiting step 
in various P450 systems (35–37). Most research on the cloning and expression of cypm and 
11α-hydroxylation of steroids was performed using heterologous expression systems, such 
as yeast, which cannot efficiently support hydroxylation. Petrič et al. (33) attempted to clone 
CYP and coexpress it with its natural redox partner (CPR) from Rhizopus oryzae in a fission 
yeast strain under inducible conditions. Compared with that by the fission yeast strain 
expressing only CYP, the total yield of hydroxyprogesterone by fission yeast strain coex-
pressing CYP and CPR increased by approximately 20 % with a 7-fold improvement in the 
bioconversion rate at 24 h. Additionally, factors such as codon preference can limit the 
heterologous expression efficiency of 11α-hydroxylase. The use of A. ochraceus as an 
Fig. 5. Time courses of canrenone conversion rates of A. ochraceus strains MF010 and MF018.
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 expression system could effectively solve these problems. A. ochraceus grows quickly and 
is easy to culture. It also provides advantages in the expression and secretion of proteins 
(38). Yang et al. (25) reported a recombinant strain of A. ochraceus TCCC41060 that could 
overexpress the steroid 11α-hydroxylase. Its transformation time was significantly reduced 
compared with that of the wild strain. After 48 h of conversion, the recombinant strain 
maintained a high 16,17a-epoxyprogesterone (EP) conversion rate (approximately 75 %) 
when EP concentrations were 5 g L–1. However, compared with the high-yielding A. ochraceus 
strain, a gap remains in the conversion rate. When 1.5 g L–1 of the surfactant Tween-80 was 
added, the conversion rate of the recombinant strain could increase to 92 % at 48 h. How-
ever, studies have demonstrated that the addition of nonionic surfactants could delay 
spore germination, inhibit cell growth, lead to membrane damage and result in cellular 
metabolite leakage. The use of excessive concentrations of organic solvents might cause 
mycelial breakage or even autolysis (39). Additionally, the use of a cosolvent might cause 
problems during product extraction, separation and purification; these problems might 
also increase the production cost.
In this study, the A. ochraceus strain MF010 exhibiting high expression of CYP mono-
oxygenase was constructed through the homologous recombination of promoter Tr and 
CYP on the chromosome. The biocatalytic rate of A. ochraceus MF010 reached approxi-
mately 93 % at 60 h without the addition of any organic solvent or surfactant. The original 
A. ochraceus strain MF018 only achieved a biocatalytic rate of approximately 75 % at 96 h 
under the same conditions. The genetic stability of this expression system was higher than 
that of heterologous expression systems, such as yeast. It can also efficiently provide the 
electrons required for the catalytic activity of the fungal steroid hydroxylase Furthermore, 
it effectively avoided the damage caused by organic solvents and surfactants and was 
beneficial for the separation and purification of 11α-hydroxycanrenone. The recombinant 
strain overcame the limitation of substrate biocatalytic efficiency and thus proved to be 
suitable for the industrial production of eplerenone.
CONCLUSIONS
In this study, an A. ochraceus recombinant strain MF010 with high CYP monooxygenase 
expression was constructed through homologous recombination. The biocatalytic rate of 
this strain was 17–18 % higher than that of the original strain MF018 without the addition 
of any organic solvent or surfactant. Its biocatalytic time was also shorter by more than 30 h 
compared with that of the MF018 strain. The MF010 strain has potential application value in 
the industrial production of eplerenone as demonstrated by its high biocatalytic efficiency 
for the production of 11α-hydroxycanrenone.
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